MIT researchers created a nanosensor catheter that detects bladder cancer biomarkers far earlier than current tests.

Bladder cancer can develop without causing someone to feel noticeably sick, which is why recognizing potential warning signs ...

Transurethral cystolithotripsy and open surgery are associated with a high stone-free rate among bladder stone cases, though ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...

The agency used a 'new approach' to broaden the drug's indication to include patients with BCG-unresponsive non-muscle invasive bladder cancer whose tumors are papillary-only.

The approval adds patients with high-grade papillary-only tumors, based on trial data showing a 62% complete response rate in ...

Nogapendekin alfa inbakicept-pmln plus BCG now covers high-grade papillary-only disease, based on extrapolation from CIS ...

A bladder cancer charity is calling on NHS Scotland to act quickly to offer routinely a urine test that can identify nine in ...

The FDA extended Anktiva to high-grade papillary-only bladder cancer that no longer responds to BCG. Its reasoning rests on a ...

FDA adds high-grade papillary-only bladder cancer to Anktiva's indication on Oct. 14, before ImmunityBio's Jan. 6, 2027 ...

A chiral cerium-doped mesoporous silica nanoreactor loaded with indocyanine green enables NIR-II fluorescence-guided bladder ...

Kidney cancer accounts for 3 percent to 5 percent of all cancer cases. It is among the top 10 most common cancers. Kidney cancer may not cause any signs or symptoms in its early stages. It is often ...